Aprea Therapeutics Announces Early Clinical Proof-Of-Concept in the Ongoing ACESOT-1051 Dose-Escalation Trial Evaluating WEE1 Inhibitor APR-1051, Including Partial Response ...

Approximately 50% reduction in target lesion and greater than 90% decrease in CA-125 observed in endometrial cancer patientThe unconfirmed ...
Healio

At 3 years after PCI, 3-month dual antiplatelet therapy noninferior to 12-month therapy

Abbreviated dual antiplatelet therapy after percutaneous coronary intervention using third-generation stents remained noninferior vs. 12-month DAPT for non-ST-segment elevation myocardial infarction ...
Medscape

A Decade After STEMI PCI, 1 in 5 Face Target Lesion Failure

Around 1 in 5 patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) experienced target lesion failure (TLF) within 10 years, ...
Medscape

Coated Balloon Treatment Reduces Complications in Complex Coronary Stent Restenosis

In patients with multilayer in-stent restenosis (ISR), treatment with a paclitaxel-coated balloon reduced target lesion failure (TLF) at 1 year to 23.8% compared with 40% with an uncoated balloon. The ...
Medical Xpress

PCI with a sirolimus-eluting balloon and provisional stenting shows promise for treatment of de novo coronary lesion

New study results from a large international all-comer population of percutaneous coronary intervention (PCI) candidates found that utilizing a strategy of sirolimus-eluting balloons with bailout ...
MedPage Today

Intravascular Lithotripsy Ekes Out a First Trial Win for PCI on Calcified Lesions

Balloon lithotripsy better prepared severely calcified lesions for stenting compared with conventional techniques, based on results of intravascular imaging in the small, 200-person BALI trial. Among ...